T. Rowe Price Investment Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25M Buy
118,752
+46,870
+65% +$10M 0.02% 515
2026
Q1
$15.9M Buy
71,882
+59,398
+476% +$14.5M 0.01% 496
2025
Q4
$3.17M Buy
12,484
+3,607
+41% +$906K ﹤0.01% 600
2025
Q3
$2.2M Buy
8,877
+2,369
+36% +$567K ﹤0.01% 610
2025
Q2
$1.56M Buy
6,508
+4,659
+252% +$1.08M ﹤0.01% 611
2025
Q1
$420K Buy
1,849
+434
+31% +$95.5K ﹤0.01% 638
2024
Q4
$291K Buy
+1,415
New +$310K ﹤0.01% 627

Other funds holding STE

T. Rowe Price Investment Management's STE Position: Q2 2026 in Review

T. Rowe Price Investment Management increased its Steris (STE) stake by 65% in Q2 2026, buying an estimated $10M and bringing the position to 118,752 shares worth $25M. The position accounts for 0.02% of the portfolio, ranked #515.

T. Rowe Price Investment Management first reported a position in STE in Q4 2024 and has held it in 7 quarters since. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • T. Rowe Price Investment Management held 118,752 shares of Steris worth $25M as of Q2 2026.
  • T. Rowe Price Investment Management bought 46,870 Steris shares in Q2 2026, an estimated $10M.
  • Steris made up 0.02% of T. Rowe Price Investment Management's portfolio in Q2 2026, its #515 holding.
  • T. Rowe Price Investment Management first reported a position in Steris in Q4 2024 and has held it in 7 quarters since.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.